10LP
 
 | | Crystal structure of mouse CD38 with compound 9 | | Descriptor: | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-5-[13-(1-cyclopropylsulfonylpyrazol-4-yl)-9-oxa-4$l^{4},6,12,14-tetrazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),2,4,10,12-pentaen-4-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl hydrogen phosphate | | Authors: | Brosey, C.A, Bigelow, L, Chapman, A, Afanador, G, Hodges, T.R. | | Deposit date: | 2026-01-27 | | Release date: | 2026-10-07 | | Method: | X-RAY DIFFRACTION (1.96 Å) | | Cite: | Design and Exploration of a Tricyclic Series of CNS-Penetrant CD38 Small Molecule Inhibitors Acs Med.Chem.Lett., 2026
|
|
10OT
 
 | | Crystal structure of mouse CD38 in complex with compound 6 | | Descriptor: | ACETATE ION, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-5-[3-[4-(1-cyclopropylsulfonylpyrazol-4-yl)pyrimidin-2-yl]imidazol-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl hydrogen phosphate | | Authors: | Jain, R, Bigelow, L. | | Deposit date: | 2026-01-29 | | Release date: | 2026-10-07 | | Method: | X-RAY DIFFRACTION (2.15 Å) | | Cite: | Design and Exploration of a Tricyclic Series of CNS-Penetrant CD38 Small Molecule Inhibitors Acs Med.Chem.Lett., 2026
|
|
10OY
 
 | | TASK-2 at pH 6.5 | | Descriptor: | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, Apolipoprotein A-I, POTASSIUM ION, ... | | Authors: | Docter, T, Li, B, Brohawn, S.G. | | Deposit date: | 2026-01-30 | | Release date: | 2026-10-07 | | Method: | ELECTRON MICROSCOPY (2.62 Å) | | Cite: | A shared site for lipid and anesthetic block of the two-pore domain K+ channel TASK-2 To Be Published
|
|
10PB
 
 | | TASK-2 L127N at pH 6.5 | | Descriptor: | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, Apolipoprotein A-I, POTASSIUM ION, ... | | Authors: | Docter, T, Li, B, Brohawn, S.G. | | Deposit date: | 2026-01-30 | | Release date: | 2026-10-07 | | Method: | ELECTRON MICROSCOPY (2.75 Å) | | Cite: | A shared site for lipid and anesthetic block of the two-pore domain K+ channel TASK-2 To Be Published
|
|
10PC
 
 | | TASK-2 at pH 6.5 with 100 uM Bupivacaine | | Descriptor: | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, Apolipoprotein A-I, POTASSIUM ION, ... | | Authors: | Docter, T, Li, B, Brohawn, S.G. | | Deposit date: | 2026-01-30 | | Release date: | 2026-10-07 | | Method: | ELECTRON MICROSCOPY (2.96 Å) | | Cite: | A shared site for lipid and anesthetic block of the two-pore domain K+ channel TASK-2 To Be Published
|
|
10PD
 
 | | TASK-2 K245A at pH 6.5 | | Descriptor: | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, POTASSIUM ION, Potassium channel TASK2 | | Authors: | Docter, T, Rietmeijer, R, Cook, A.S.I, Brohawn, S.G. | | Deposit date: | 2026-01-30 | | Release date: | 2026-10-07 | | Method: | ELECTRON MICROSCOPY (3.22 Å) | | Cite: | A shared site for lipid and anesthetic block of the two-pore domain K+ channel TASK-2 To Be Published
|
|
10PF
 
 | | TASK-2 at pH 8.5 with 100 uM Bupivacaine | | Descriptor: | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, Apolipoprotein A-I, Bupivacaine, ... | | Authors: | Docter, T, Li, B, Brohawn, S.G. | | Deposit date: | 2026-01-30 | | Release date: | 2026-10-07 | | Method: | ELECTRON MICROSCOPY (3.06 Å) | | Cite: | A shared site for lipid and anesthetic block of the two-pore domain K+ channel TASK-2 To Be Published
|
|
10ZP
 
 | |
11ES
 
 | |
11FB
 
 | |
11FL
 
 | |
11FT
 
 | |
11FU
 
 | |
11GH
 
 | |
11HT
 
 | | Cryo-EM structure of the human ZNFX1 tetramer | | Descriptor: | NFX1-type zinc finger-containing protein 1, PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER | | Authors: | Wang, F, He, Q, Li, H. | | Deposit date: | 2026-02-25 | | Release date: | 2026-10-07 | | Method: | ELECTRON MICROSCOPY (3.71 Å) | | Cite: | Cryo-EM structures of autoinhibited and RNA-activated ZNFX1 helicase Nat Commun, 2026
|
|
11IM
 
 | |
11RI
 
 | | D189A thrombin inhibited with D-Phe-Pro-Gln-Chloromethylketone | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, D-phenylalanyl-N-[(2S,3S)-6-amino-1-chloro-2-hydroxy-6-oxohexan-3-yl]-L-prolinamide, SODIUM ION, ... | | Authors: | Friet, T, Mohammed, B.M, Sukumar, N, Di Cera, E. | | Deposit date: | 2026-03-10 | | Release date: | 2026-10-07 | | Method: | X-RAY DIFFRACTION (1.2 Å) | | Cite: | Structural analysis of the primary specificity of thrombin. J.Thromb.Haemost., 2026
|
|
11RJ
 
 | | D189A thrombin inhibited with D-Phe-Pro-Arg-Chloromethylketone | | Descriptor: | D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide, SODIUM ION, Thrombin heavy chain, ... | | Authors: | Friet, T, Mohammed, B.M, Sukumar, N, Di Cera, E. | | Deposit date: | 2026-03-10 | | Release date: | 2026-10-07 | | Method: | X-RAY DIFFRACTION (2.5 Å) | | Cite: | Structural analysis of the primary specificity of thrombin. J.Thromb.Haemost., 2026
|
|
11RK
 
 | | D189A thrombin inhibited with D-Phe-Pro-Phe-Chloromethylketone | | Descriptor: | D-phenylalanyl-N-[(2S,3S)-4-chloro-3-hydroxy-1-phenylbutan-2-yl]-L-prolinamide, SODIUM ION, Thrombin heavy chain, ... | | Authors: | Friet, T, Mohammed, B.M, Sukumar, N, Di Cera, E. | | Deposit date: | 2026-03-10 | | Release date: | 2026-10-07 | | Method: | X-RAY DIFFRACTION (2.12 Å) | | Cite: | Structural analysis of the primary specificity of thrombin. J.Thromb.Haemost., 2026
|
|
11SS
 
 | |
11UY
 
 | |
11VG
 
 | | D189F thrombin inhibited with D-Phe-Pro-Gln-Chloromethylketone | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, D-phenylalanyl-N-[(2S,3S)-6-amino-1-chloro-2-hydroxy-6-oxohexan-3-yl]-L-prolinamide, Thrombin heavy chain, ... | | Authors: | Friet, T, Mohammed, B.M, Sukumar, N, Di Cera, E. | | Deposit date: | 2026-03-13 | | Release date: | 2026-10-07 | | Method: | X-RAY DIFFRACTION (2.13 Å) | | Cite: | Structural analysis of the primary specificity of thrombin. J.Thromb.Haemost., 2026
|
|
11VJ
 
 | |
11XW
 
 | | D189F thrombin inhibited with D-Phe-Pro-Arg-Chloromethylketone | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, ACETATE ION, D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide, ... | | Authors: | Friet, T, Mohammed, B.M, Sukumar, N, Di Cera, E. | | Deposit date: | 2026-03-17 | | Release date: | 2026-10-07 | | Method: | X-RAY DIFFRACTION (1.88 Å) | | Cite: | Structural analysis of the primary specificity of thrombin. J.Thromb.Haemost., 2026
|
|
11YH
 
 | | D189F thrombin inhibited with D-Phe-Pro-Phe-Chloromethylketone | | Descriptor: | D-phenylalanyl-N-[(2S,3S)-4-chloro-3-hydroxy-1-phenylbutan-2-yl]-L-prolinamide, Thrombin heavy chain, Thrombin light chain | | Authors: | Friet, T, Mohammed, B.M, Korolev, S, Di Cera, E. | | Deposit date: | 2026-03-18 | | Release date: | 2026-10-07 | | Method: | X-RAY DIFFRACTION (2.2 Å) | | Cite: | Structural analysis of the primary specificity of thrombin. J.Thromb.Haemost., 2026
|
|